Skip to content

Evaluation of Perioperative Cystoscopy and Methylene Blue Test in Detecting Complications in TVT and TOT Procedures

Comparison of Complications Detected by Perioperative Cystoscopy Combined With Methylene Blue Test and Postoperative Cystoscopy in TVT and TOT Operations

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06801938
Enrollment
58
Registered
2025-01-30
Start date
2025-01-01
Completion date
2026-01-01
Last updated
2025-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incontinence Stress

Keywords

tvt, tot, cystoscopy

Brief summary

Comparison of complications detected by perioperative cystoscopy combined with methylene blue test and postoperative cystoscopy in TVT and TOT operations.

Interventions

PROCEDUREPerioperative Cystoscopy and Methylene Blue Test

The ability of perioperative methylene blue and cystoscopy versus postoperative cystoscopy to detect complications will be compared in patients.

Sponsors

Gaziosmanpasa Research and Education Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The ability of perioperative methylene blue test and postoperative cystoscopy to detect complications in patients with stress urinary incontinence will be compared.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Providing consent to participate in the study * Being between the ages of 18 and 85 * Having stress urinary incontinence * No active cardiac disease * No connective tissue disorders (e.g., Marfan syndrome) * No known gynecological malignancy * BMI under 30 * No chronic constipation * No inflammatory bowel disease

Exclusion criteria

* Not providing consent to participate in the study * Being under 18 or over 85 years old * Not having stress urinary incontinence * Having active cardiac disease * Having connective tissue disorders (e.g., Marfan syndrome) * Having a known gynecological malignancy * Having a BMI over 30 * Having chronic constipation * Having inflammatory bowel disease

Design outcomes

Primary

MeasureTime frameDescription
rate of complication detection6 monthsSpecifically, it would compare the ability of the perioperative methylene blue test and cystoscopy versus postoperative cystoscopy to detect complications. This measure will be used to evaluate the accuracy and effectiveness of both methods

Countries

Turkey (Türkiye)

Contacts

Primary ContactFatma Ketenci Gencer, Associate Professor
fathma_k@hotmail.com+905416116469
Backup ContactHavva Betül Bacak, Specialist
hbbacak90@gmail.com+905333610088

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026